Advanced NSCLC: Clinical Trials

1 trial for Advanced NSCLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Advanced NSCLC: new trials by email Literature Review of Advanced NSCLC trials Research Report on Advanced NSCLC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
JS207 injection +docetaxel, JS207 injection +JS004 injection, JS207 injection - Advanced NSCLC
Phase 2TerminatedShanghai Junshi Bioscience Co., Ltd.182025-07-152026-09-25

Sponsors

Shanghai Junshi Bioscience Co., Ltd. (1)

Countries

China (1)